Cytosorbents Balance Sheet Health
Financial Health criteria checks 2/6
Cytosorbents has a total shareholder equity of $13.0M and total debt of $13.8M, which brings its debt-to-equity ratio to 106.2%. Its total assets and total liabilities are $47.8M and $34.8M respectively.
Key information
106.2%
Debt to equity ratio
US$13.81m
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.69m |
| Equity | US$13.00m |
| Total liabilities | US$34.80m |
| Total assets | US$47.80m |
Recent financial health updates
Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
Mar 16
Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?
Nov 10Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
May 16We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Mar 08Recent updates
Further Upside For Cytosorbents Corporation (NASDAQ:CTSO) Shares Could Introduce Price Risks After 28% Bounce
Jan 17The Market Lifts Cytosorbents Corporation (NASDAQ:CTSO) Shares 43% But It Can Do More
Oct 01Investors Continue Waiting On Sidelines For Cytosorbents Corporation (NASDAQ:CTSO)
Jul 04Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
Mar 16Take Care Before Jumping Onto Cytosorbents Corporation (NASDAQ:CTSO) Even Though It's 28% Cheaper
Jan 06Is Cytosorbents (NASDAQ:CTSO) Using Too Much Debt?
Nov 10Shareholders Should Be Pleased With Cytosorbents Corporation's (NASDAQ:CTSO) Price
Jul 13Health Check: How Prudently Does Cytosorbents (NASDAQ:CTSO) Use Debt?
May 16We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Mar 08CytoSorbents secures $4.3M contract by U.S. Department of Defense
Oct 06CytoSorbents stock rises on US DoD contract to develop device for universal plasma
Sep 09We're A Little Worried About Cytosorbents' (NASDAQ:CTSO) Cash Burn Rate
Sep 02CytoSorbents gets reimbursement for CytoSorb in Turkey
Aug 23Financial Position Analysis
Short Term Liabilities: CTSO's short term assets ($16.6M) exceed its short term liabilities ($8.4M).
Long Term Liabilities: CTSO's short term assets ($16.6M) do not cover its long term liabilities ($26.4M).
Debt to Equity History and Analysis
Debt Level: CTSO's net debt to equity ratio (62.5%) is considered high.
Reducing Debt: CTSO's debt to equity ratio has reduced from 223% to 106.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CTSO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CTSO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 14.1% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 20:34 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cytosorbents Corporation is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jonathan Aschoff | Brean Capital |
| Jason Kolbert | D. Boral Capital LLC. |
| Swayampakula Ramakanth | H.C. Wainwright & Co. |